Pergamum AB Report issue

For profit Phase 2
Founded: Solna Sweden (2009)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2009
NCT01022242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Mergers & Acquisitions

Historical Acquisition Tree